Rx News Connection: December 2021
Price $0.00
Credits 0.5
Format
In the medical arena, information changes quickly. What was irrelevant yesterday, may be paramount today. PharmCon’s News Connection series seeks to distill the most impactful news for health professionals from the vast sea of news that confronts us all, then bridge the gap between the immediacy of those critical items and the delay that occurs as that information is incorporated into more focused programming. Our team of skilled editors continually scans the emerging medical news to bring the most relevant pieces to the forefront and deliver them to you in a concise, practical manner. In this session, we investigate timely items, including: Early treatment with fluvoxamine reduces COVID-19 hospitalizations in high risk patients, COVID-19 vaccine boosters clarified, mirtazipine does not improve dementia agitation, atorvastatin for ulcerative colitis, varenicline nasal spray approved for dry eye disease, new recommendation for Shingrix® shingles vaccine may lower the risk of dementia